Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
Abstract Background Alopecia areata (AA) is an auto‐immune disorder characterized by non‐scarring hair loss. With the emergence of effective therapies for severe AA, there is a need to better understand the prognosis of untreated AA, specifically the potential for spontaneous hair regrowth. Objectiv...
Saved in:
| Main Authors: | Abraham Zlotogorski, Sergio Vañó‐Galván, Bianca Maria Piraccini, Frederick Durand, Guanglei Yu, Chiara Chiasserini, Na Lu, Arash Mostaghimi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | JEADV Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jvc2.455 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
by: Ernest H. Law, et al.
Published: (2025-12-01) -
Complementing baricitinib response in late-responding alopecia areata through alternating weekly double combination of topical corticosteroids: A split-scalp comparison
by: Calogero Pagliarello, MD, PhD, et al.
Published: (2025-08-01) -
Janus kinase inhibitors for alopecia areata: a review of clinical data
by: Yutong Sun, et al.
Published: (2025-05-01) -
Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
by: Manuel Darío Franco, et al.
Published: (2024-01-01) -
Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
by: Daniel Muñoz-Barba, et al.
Published: (2025-07-01)